journal article Open Access Nov 20, 2025

A National Audit of Current UK Practice on the Use of Anti‐Emetics for Chemotherapy‐Induced Nausea and Vomiting in Children

View at Publisher Save 10.1002/mpo.70013
Abstract
ABSTRACT
This UK national audit aimed to assess adherence to evidence‐based chemotherapy‐induced nausea and vomiting (CINV) guidelines for children with cancer, which emphasise treatment emetogenicity assessment, symptom monitoring and appropriate antiemetic use. Data from 99 inpatient episodes in 12 centres were collected over 5 days in January 2024 via an anonymised survey. Concordance with 2018 CCLG guidelines was 83%, with 6% of cases overestimated and 11% underestimated levels of emetogenicity. This first UK national audit demonstrates generally good alignment with guidelines. Future audits should include prescribing practices in outpatient and ambulatory settings to provide a more comprehensive evaluation of CINV management.
Topics

No keywords indexed for this article. Browse by subject →

References
16
[7]
“CCLG Guideline on the Management of Chemotherapy‐Induced Nausea and Vomiting ”Children's Cancer and Leukaemia Group published March 2018 https://www.piernetwork.org/uploads/4/7/8/1/47810883/cclg_cinv_guideline_march_2018.pdf.
Metrics
0
Citations
16
References
Details
Published
Nov 20, 2025
Vol/Issue
73(2)
License
View
Cite This Article
Eloise Neumann, Thomas J. Jackson, Jessica E. Morgan, et al. (2025). A National Audit of Current UK Practice on the Use of Anti‐Emetics for Chemotherapy‐Induced Nausea and Vomiting in Children. Pediatric Blood & Cancer, 73(2). https://doi.org/10.1002/mpo.70013